Table 10

Clinicopathological parameters in relation to p21^WAF1 expression in the tumour

	p21^WAF1 expression		p Value
	<6%	⩾6%	p Value
ER, oestrogen receptor; p34^cdc2bn, p34^cdc2 expression in benign breast tissue; p34^cdc2TC, p34^cdc2 expression in tumour cytoplasm; p34^cdc2TN, p34^cdc2 expression in tumour nuclei; PR, progesterone receptor.
Age (years)
<50	21	19
⩾50	27	27	0.813
Menopausal
Pre	18	17
Post	29	28	0.960
T size
T1	20	24
T2	28	22	0.313
Grade
1	10	11
2	17	21
3	21	14	0.299
p34^cdc2TN
<10%	8	6
⩾10%	40	40	0.626
p34^cdc2TC
<10%	13	16
⩾10%	34	20	0.379
p34^cdc2bn
<10%	30	32
⩾10%	6	6	0.920
p53
<10%	32	37
⩾10%	13	8	0.217
ER
Negative	23	14
Positive	25	29	0.140
PR
Negative	27	19
Positive	21	26	0.180
Relapse
No	40	42
Yes	8	4	0.252
Death
No	43	43
Yes	5	3	0.504

Expression of the cell cycle regulatory proteins p34^cdc2, p21^waf1, and p53 in node negative invasive ductal breast carcinoma

Pathology jobs